Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis
Covid19-Sources
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
SARS-CoV-2 infects cells lining the blood-retinal barrier and induces a hyperinflammatory immune response in the retina via systemic exposure
What do we know about covid-19’s effects on the brain?
Presentation UnitedtoFight_D. Beckman_2.pdf | Powered by Box
COVID-19: Sterberate höher als bei der Grippe
Ralf Wittenbrink (@ralfwittenbrink.bsky.social)
SARS-CoV-2 infection as a cause of neurodegeneration
Brain abnormalities in survivors of COVID-19 after 2-year recovery: a functional MRI study
Weitere Studie zeigt: Masken und Luftreiniger reduzieren SARS-CoV-2-Übertragung
Klärung falscher Aussagen zur Keuchhusten-Welle in der Schweiz
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial
Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue
Cognition and Memory after Covid-19 in a Large Community Sample | NEJM
Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel- group trial. Results of the first interim analysis
Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis
1.66 g L-arginine twice a day
Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial - PubMed
combination of 1.66 g l-arginine plus 500 mg liposomal vitamin C
Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey - PubMed
Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenes
Fig. 1: Trend in S. pyogenes-positive samples, England 2016–2023.Data show absolute numbers of weekly S. pyogenes-positive samples from non-sterile sites (light blue bars, left hand, positive axis) and sterile sites (dark blue bars, right hand, negative axis) recorded by the Second Generation Surveillance System (SGSS) in England, by week and by year. Timing of non-pharmaceutical interventions (NPI) related to COVID-19 in England is indicated by the horizontal bar: red, lockdown periods; orange, legally enforced NPI including no mixing; yellow, non-severe NPI. Schools were closed during lockdown periods and between the two later lockdown periods except for children of key workers and vulnerable children. Source data are provided as a Source Data file Fig. 1.
SARS-CoV-2 aberrantly elevates mitochondrial bioenergetics to induce robust virus propagation
An incomplete picture: understanding the burden of long Covid
Can the Japanese Encephalitis Vaccine Reduce Symptoms of Long COVID? - Health Rising
"SARS-CoV-2 triggers the up-regulation of synaptic components and perturbs local electrical field potential" (see also )
Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms
SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway - Fluids and Barriers of the CNS
Brain abnormalities in survivors of COVID-19 after 2-year recovery: a functional MRI study
Autonomic cardiac function in children and adolescents with long COVID: a case-controlled study
Robust neutralization of SARS-CoV-2 variants including JN.1 and BA.2.87.1 by trivalent XBB vaccine-induced antibodies
Do mobile phone surfaces carry SARS-CoV-2 virus? A systematic review warranting the inclusion of a “6th” moment of hand hygiene in healthcare